IPP Bureau
Arum Therapeutics implements CDD Vault to streamline research data
By IPP Bureau - March 23, 2022
Arum's research focuses on the discovery of new chemical entities that will act as effective therapies for drug-resistant cancers
IHL launches first zero assistance integrated health centre
By IPP Bureau - March 23, 2022
The first-of-its-kind unique centre will increase access to preventive & primary care
Pfizer voluntary recall of drugs in the US
By IPP Bureau - March 23, 2022
Voluntary nationwide recall of lots of Accuretic (quinapril HCl/hydrochlorothiazide), quinapril and hydrochlorothiazide tablets, and quinapril HCl/hydrochlorothiazide tablets due to n-nitroso- quinapril content
Lonza appoints Christian Seufert as President of CHI Division
By IPP Bureau - March 23, 2022
Christian brings a unique level of experience and expertise from a 20-year career at BASF across multiple territories and businesses
Glamyo Health, now available in 300 centres
By IPP Bureau - March 23, 2022
The company is Series A funded with US $ 7 million in funding so far
Roquette to invest €25 million in liquid, polyols production
By IPP Bureau - March 23, 2022
The investment will improve equipment efficiency and increase safety standards at its Lestrem site
Waters introduces automated solutions for mass and purity analysis of biomolecules
By IPP Bureau - March 23, 2022
New line of Waters MaxPeak Premier columns further enhances the analysis by delivering 2x to 3x greater sensitivity than conventional steel columns
GOQii India Fit Report 2022 indicates stress levels high amongst Indians
By IPP Bureau - March 23, 2022
The survey indicates that 30% of people are still feeling depressed or hopeless on a few days as against GOQii’s last year survey on mental Health where 43% of Indians were depressed
Huma acquires AstraZeneca health platform AMAZE
By IPP Bureau - March 23, 2022
As part of this partnership, Huma and AstraZeneca will launch Software as a Medical Device (SaMD) companion apps targeted at several therapeutic areas and will partner to help accelerate the adoption of decentralized clinical trials
Thyssenkrupp bags order for a pharma-grade SFE plant for solids extraction
By IPP Bureau - March 23, 2022
The scope of supply includes the skid-mounted plant as well as on-site installation and commissioning support
Wipro GE Healthcare bolsters leadership bench in India & South Asia
By IPP Bureau - March 23, 2022
This announcement comes after the formation of a new Intercontinental Region within GE Healthcare, led by Chaillot
GMP certification for Exothera further extends its viral vector manufacturing capacity
By IPP Bureau - March 23, 2022
The expansion makes Exothera one of the largest viral vector facilities in Europe
M2 milk platform to develop cell-cultured milk
By IPP Bureau - March 22, 2022
Building the future of food in the birthplace of cell-cultured milk
Bristol Myers Squibb to demonstrate growing cardiovascular portfolio
By IPP Bureau - March 22, 2022
New data, including two late-breaking clinical trial presentations on mavacamten and a new analysis of the GUARD-AF study, reinforce the company’s continued commitment to those living with cardiovascular disease
AbbVie and Allergan Aesthetics to present new research at 2022 AAD annual meeting
By IPP Bureau - March 22, 2022
Twelve abstracts and two late-breaking presentations demonstrate AbbVie and Allergan Aesthetics' shared commitment to advancing research across a spectrum of dermatologic conditions and aesthetic indications
